Health

MyoKardia presents cardiac imaging data from Mavacamten’s 30-week EXPLORER-HCM study

[ad_1] EXPLORER-HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Concurrent Publication in Circulation Mavacamten T.reatment Caused Favorable effect on Cardiac structure – Significantly reduced Hypertrophy in patients with hypertrophic cardiomyopathy BRISBANE, Calif., November 15, 2020 (GLOBE NEWSWIRE) – MyoKardia, Inc. (Nasdaq: MYOK) has announced the results of …

Read More »